6 withdrawn. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Withdrawn 6 |
| Phase 2 | 2 | Withdrawn 2 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases CLBR001 + SWI019 - Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc) | Phase 1 | Withdrawn | Calibr, a division of Scripps Research | 2026-03-01 | 2026-03-05 | |
| Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases Autologous CD19-BCMA Dual-Target CAR T-Cell Therapy - Relapsed/Refractory Systemic Lupus Erythematosus, Relapsed/Refractory Systemic Sclerosis | Phase 1 | Withdrawn | Beijing Boren Hospital | 2025-11-06 | 2026-10-15 | |
| A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc) TAK-007, Chemotherapy Agents - Refractory Lupus Nephritis, Refractory Systemic Sclerosis | Phase 1 | Withdrawn | Takeda | 2025-06-13 | 2025-04-06 | |
| A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis FCR001 - Diffuse Cutaneous Systemic Sclerosis | Phase 1 / Phase 2 | Withdrawn | Talaris Therapeutics Inc. | 2021-11-24 | 2023-10-12 | |
| Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea Clobetasol, Calcipotriene, Tacrolimus - Scleroderma | Phase 1 | Withdrawn | Medical College of Wisconsin | 2016-03-01 | 2018-07-18 | |
| Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma Divalproex sodium - Scleroderma, Systemic Sclerosis | Phase 1 / Phase 2 | Withdrawn | Yale University | 2014-06-01 | 2016-08-11 |
Scleroderma, Diffuse (3) · Lupus Erythematosus, Systemic (2) · Myositis (2) · Anemia, Hemolytic, Autoimmune (1) · Lupus Nephritis (1) · Multiple Sclerosis (1) · Sjogren's Syndrome (1)
Connective Tissue Diseases (6) · Skin Diseases (6) · Skin and Connective Tissue Diseases (6) · Autoimmune Diseases (3) · Immune System Diseases (3) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Anemia (1) · Anemia, Hemolytic (1) · Arthritis (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases of the Nervous System (1)
Clobetasol (1) · Tacrolimus (1) · Valproic Acid (1) · calcipotriene (1)
Beijing Boren Hospital (1) · Calibr, a division of Scripps Research (1) · Medical College of Wisconsin (1) · Takeda (1) · Talaris Therapeutics Inc. (1) · Yale University (1)
United States (3) · China (1)
Brett King, MD, PhD (1) · Joel Weinthal, MD (1) · Yvonne Chiu, MD (1)